Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

4015 results

Sort By:

rTMS for Aneroxia Nervosa in Youth

Study ID: NCT04846517
Start Date: 2028-01-30
End Date: 2030-01-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

45

Intervention / Treatment

Transcranial Magnetic Treatment

Sponsor

University of California, Los Angeles

Source: clinicaltrials.gov

Share:
Add to list

Rapid Identification of Infectious Pathogens in Severe Pneumonia Guided by Bronchoscopic Imaging and Lung CT

Study ID: NCT07308340
Start Date: 2026-05-01
End Date: 2026-12-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

400

Intervention / Treatment

Standalone Lung CT for Severe Pneumonia Diagnosis

Bronchoscopic Imaging + Lung CT for Severe Pneumonia diagnosis

Sponsor

The First Hospital of Jilin University

Source: clinicaltrials.gov

Share:
Add to list

A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)

Study ID: NCT07440225
Start Date: 2026-03-31
End Date: 2028-06-30
Study Type

Interventional

Study Phase

Phase3

No. of Participants

960

Intervention / Treatment

Tiespectus

Aflibercept

Sponsor

EyeBiotech Ltd.

Source: clinicaltrials.gov

Share:
Add to list

Expanded Hemodialysis Versus High-Volume Online Hemodiafiltration for Uremic Toxin Removal

Study ID: NCT07348536
Start Date: 2026-04
End Date: 2029-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

15

Intervention / Treatment

Expanded Hemodialysis With Medium Cut-Off Membrane

High-Volume Online Hemodiafiltration

Sponsor

National Institute of Medical Sciences and Nutrition Salvador Zubiran

Source: clinicaltrials.gov

Share:
Add to list

Study to Assess Effects of Ublituximab in Pediatric Participants With Relapsing Forms of Multiple Sclerosis

Study ID: NCT07220252
Start Date: 2026-03-31
End Date: 2033-06-30
Study Type

Interventional

Study Phase

Phase3

No. of Participants

240

Intervention / Treatment

Ublituximab

Placebo

Placebo

Fingolimod

Sponsor

TG Therapeutics, Inc.

Source: clinicaltrials.gov

Share:
Add to list

AI-Supported Empathy Mapping to Enhance Communication and Grit in Pediatric Nursing Students

Study ID: NCT07370285
Start Date: 2026-04-20
End Date: 2027-08-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

66

Intervention / Treatment

AI-Supported Empathy-Map Scaffolding Model

Sponsor

Mackay Memorial Hospital

Source: clinicaltrials.gov

Share:
Add to list

MDMA-Assisted Therapy for Veterans With PTSD and Alcohol Use Disorder

Study ID: NCT07118839
Start Date: 2026-04-15
End Date: 2030-05-30
Study Type

Interventional

Study Phase

Phase3

No. of Participants

80

Intervention / Treatment

Full Dose MDMA

MDMA-AT

Active Placebo Dose MDMA

Sponsor

VA Office of Research and Development

Source: clinicaltrials.gov

Share:
Add to list

Tecar Therapy in Chronic Knee Osteoarthritis

Study ID: NCT07438392
Start Date: 2026-04-01
End Date: 2026-08-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

60

Intervention / Treatment

Tecar Therapy

ShamTecar Therapy

conventional physical therapy

Sponsor

Kirsehir Ahi Evran University

Source: clinicaltrials.gov

Share:
Add to list

To Evaluate the Efficacy, Safety, and Tolerability of Dronabinol Oral Solution for Agitation in Patients With Alzheimer's Disease

Study ID: NCT07422311
Start Date: 2026-05-01
End Date: 2028-08-01
Study Type

Interventional

Study Phase

Phase3

No. of Participants

140

Intervention / Treatment

Dronabinol Oral Solution

Placebo Control

Sponsor

Benuvia Therapeutics Inc.

Source: clinicaltrials.gov

Share:
Add to list

Efficacy of Intravenous Oxytocin to Speed Recovery After THA

Study ID: NCT07430228
Start Date: 2026-05
End Date: 2027-05
Study Type

Interventional

Study Phase

Phase2

No. of Participants

80

Intervention / Treatment

intravenous administration of oxytocin

Placebo

Sponsor

Wake Forest University Health Sciences

Source: clinicaltrials.gov

Share:
Add to list